Showing results (121-130 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|March 1, 1997
Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminaseZ Li, N Shanmugam, D Katayose, et al.Cancer Gene Therapy|February 4, 2006
Endostatin therapy reveals a U-shaped curve for antitumor activityR M Tjin Tham Sjin, J Naspinski, A E Birsner, et al.Cancer Gene Therapy|January 1, 1997
A comparison of gene transfer methods in human dendritic cellsJ F Arthur, L H Butterfield, M D Roth, et al.Cancer Gene Therapy|January 1, 1997
Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistanceS E Braun, R S McIvor, A S Davidson, et al.Cancer Gene Therapy|September 1, 1996
Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivityS Sharma, J Wang, M Huang, et al.Cancer Gene Therapy|September 1, 1996
Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cellsF J Staal, A Q Bakker, M Verkuijlen, et al.Cancer Gene Therapy|May 17, 2008
A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexateS Kraljevic Pavelic, T Cacev, M KraljCancer Gene Therapy|May 17, 2008
Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cellsR A Abela, J Qian, L Xu, et al.Cancer Gene Therapy|May 24, 2008
Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapyK-F Hsu, C-L Wu, S-C Huang, et al.Cancer Gene Therapy|May 10, 2008
In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation methodS S Yu, I Nukaya, T Enoki, et al.Pageof 291